The department may establish the PFAS biomonitoring pilot program for the following purposes:

1. (1) To collect blood samples from individuals described in section 6 of this chapter for the purposes of measuring serum PFAS levels.
2. (2) To determine, to the extent possible, whether there are any health implications that may be attributed to elevated serum PFAS levels.
3. (3) To identify regions of the state where individuals described in section 6 of this chapter may experience exposure to PFAS chemicals in higher concentrations.

As added by P.L.132-2023, SEC.1.